ICD-10 Coding for COVID-19 Testing(J12.89U, U07.1, U07.1B)
Explore detailed ICD-10 coding guidelines for COVID-19 testing, including confirmed cases, screening, and exposure scenarios. Updated for FY2025.
Complete code families applicable to COVID-19 Testing
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| U07.1 | COVID-19, virus identified | Use for confirmed COVID-19 cases with positive test results. |
|
| Z11.52 | Encounter for screening for COVID-19 | Use for asymptomatic screening encounters. |
|
| Z20.828 | Contact with and (suspected) exposure to other viral communicable diseases | Use when there is a history of exposure and symptoms are present. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCOVID-19 Testing
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting COVID-19 Testing.
Using Z11.52 for symptomatic patients
Impact
Clinical: Misrepresentation of patient's clinical status, Regulatory: Non-compliance with coding guidelines, Financial: Potential claim denials
Mitigation
Verify symptom presence before coding, Use Z20.828 if symptoms and exposure are present
Using U07.1 without provider confirmation post-April 2025
Impact
Reimbursement: Potential denial of claims, Compliance: Non-compliance with updated guidelines, Data Quality: Inaccurate data reporting
Mitigation
Ensure provider confirmation is documented for U07.1.
Incorrect use of U07.1
Impact
Coding U07.1 without provider confirmation post-April 2025.
Mitigation
Implement checks for provider confirmation in documentation.